OSR HEALTH, INC. Increase (Decrease) in Other Operating Liabilities
OSR HEALTH, INC. (OSRH) reported Increase (Decrease) in Other Operating Liabilities of -$2.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-14
- OSR HEALTH, INC. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was -$2.34M.
- OSR HEALTH, INC. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $44.50K, a 396.47% increase year-over-year.
- OSR HEALTH, INC. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $30.85K, a 166.17% increase year-over-year.
- OSR HEALTH, INC. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$30.27K, a 959.02% decline year-over-year.
- OSR HEALTH, INC. increase (decrease) in other operating liabilities for fiscal 2025 was -$44.84K, a 649.39% decline from fiscal 2024.
- OSR HEALTH, INC. increase (decrease) in other operating liabilities for fiscal 2024 was $8.16K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$2.30M 10-Q · filed 2026-08-14 | -$2.27M derived: sum of 3 quarters · filed 2026-08-14 | -$2.30M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $44.50K 10-Q · filed 2026-05-13 | $75.35K derived: sum of 2 quarters · filed 2026-05-13 | $45.08K derived: sum of 3 quarters · filed 2026-05-13 | -$9.31K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $30.85K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $580.00 derived: sum of 2 quarters · filed 2026-03-31 | -$53.80K derived: sum of 3 quarters · filed 2026-08-14 | -$44.84K 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$30.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$84.66K derived: sum of 2 quarters · filed 2026-08-14 | -$75.69K 10-Q · filed 2025-11-12 | -$64.10K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$54.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$45.42K 10-Q · filed 2026-08-14 | -$33.83K derived: sum of 3 quarters · filed 2026-08-14 | -$30.31K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $8.96K 10-Q · filed 2026-05-13 | $8.96K 10-Q · filed 2025-05-20 | $20.55K derived: sum of 2 quarters · filed 2026-05-13 | $24.08K derived: sum of 3 quarters · filed 2026-05-13 | $20.66K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $11.59K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $15.12K derived: sum of 2 quarters · filed 2026-03-31 | $11.69K derived: sum of 3 quarters · filed 2026-03-31 | $8.16K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $3.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $103.00 derived: sum of 2 quarters · filed 2025-11-12 | -$3.43K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$3.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$6.95K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | -$3.53K 10-Q · filed 2025-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |